These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Progress toward poliomyelitis eradication--Chad, January 2011-August 2012. Centers for Disease Control and Prevention MMWR Morb Mortal Wkly Rep; 2012 Oct; 61(42):858-62. PubMed ID: 23095955 [TBL] [Abstract][Full Text] [Related]
44. Health Economic Analysis of Antiviral Drugs in the Global Polio Eradication Endgame. Badizadegan K; Kalkowska DA; Thompson KM Med Decis Making; 2023; 43(7-8):850-862. PubMed ID: 37577803 [TBL] [Abstract][Full Text] [Related]
45. The global polio eradication initiative: lessons learned and prospects for success. Aylward B; Tangermann R Vaccine; 2011 Dec; 29 Suppl 4():D80-5. PubMed ID: 22486981 [TBL] [Abstract][Full Text] [Related]
46. Progress Toward Poliomyelitis Eradication - Pakistan, January 2020-July 2021. Mbaeyi C; Baig S; Khan Z; Young H; Kader M; Jorba J; Safdar MR; Jafari H; Franka R MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(39):1359-1364. PubMed ID: 34591827 [TBL] [Abstract][Full Text] [Related]
49. Health economic analysis of vaccine options for the polio eradication endgame: 2022-2036. Thompson KM; Kalkowska DA; Badizadegan K Expert Rev Vaccines; 2022 Nov; 21(11):1667-1674. PubMed ID: 36154436 [TBL] [Abstract][Full Text] [Related]
50. The risk of type 2 oral polio vaccine use in post-cessation outbreak response. McCarthy KA; Chabot-Couture G; Famulare M; Lyons HM; Mercer LD BMC Med; 2017 Oct; 15(1):175. PubMed ID: 28974220 [TBL] [Abstract][Full Text] [Related]
51. Virologic Monitoring of Poliovirus Type 2 after Oral Poliovirus Vaccine Type 2 Withdrawal in April 2016 - Worldwide, 2016-2017. Diop OM; Asghar H; Gavrilin E; Moeletsi NG; Benito GR; Paladin F; Pattamadilok S; Zhang Y; Goel A; Quddus A MMWR Morb Mortal Wkly Rep; 2017 May; 66(20):538-542. PubMed ID: 28542124 [TBL] [Abstract][Full Text] [Related]
52. Modeling the spread of circulating vaccine-derived poliovirus type 2 outbreaks and interventions: A case study of Nigeria. Sun Y; Keskinocak P; Steimle LN; Kovacs SD; Wassilak SG Vaccine X; 2024 Jun; 18():100476. PubMed ID: 38617838 [TBL] [Abstract][Full Text] [Related]
53. Impact of COVID-19 Pandemic on Global Poliovirus Surveillance. Zomahoun DJ; Burman AL; Snider CJ; Chauvin C; Gardner T; Lickness JS; Ahmed JA; Diop O; Gerber S; Anand A MMWR Morb Mortal Wkly Rep; 2021 Jan; 69(5152):1648-1652. PubMed ID: 33382673 [TBL] [Abstract][Full Text] [Related]
54. Genetic and epidemiological description of an outbreak of circulating vaccine-derived polio-virus type 2 (cVDPV2) in Angola, 2019-2020. Morais A; Morais J; Felix M; Neto Z; Madaleno V; Umar AS; Panda N; Lemma F; Chivale JAL; Cavalcante DG; Davlantes E; Ghiselli M; Espinosa C; Whiteman A; Iber J; Henderson E; Bullard K; Jorba J; Burns CC; Diop O; Gumede N; Seakamela L; Howard W; Frawley A Vaccine; 2023 Apr; 41 Suppl 1(Suppl 1):A48-A57. PubMed ID: 36803869 [TBL] [Abstract][Full Text] [Related]
55. Impact of COVID-19 on polio vaccination in Pakistan: a concise overview. Din M; Ali H; Khan M; Waris A; Ullah S; Kashif M; Rahman S; Ali M Rev Med Virol; 2021 Jul; 31(4):e2190. PubMed ID: 33176028 [TBL] [Abstract][Full Text] [Related]
56. Strengthening the partnership between routine immunization and the global polio eradication initiative to achieve eradication and assure sustainability. Abdelwahab J; Dietz V; Eggers R; Maher C; Olaniran M; Sandhu H; Vandelaer J J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S498-503. PubMed ID: 25316872 [TBL] [Abstract][Full Text] [Related]
57. Outbreak response strategies with type 2-containing oral poliovirus vaccines. Kalkowska DA; Wassilak SGF; Pallansch MA; Burns CC; Wiesen E; Durry E; Badizadegan K; Thompson KM Vaccine; 2023 Apr; 41 Suppl 1(Suppl 1):A142-A152. PubMed ID: 36402659 [TBL] [Abstract][Full Text] [Related]
58. Global Polio Eradication,The Journey So Far. Thacker N; Yewale VN; Pathak A Indian Pediatr; 2016 Aug; 53 Suppl 1():S61-S64. PubMed ID: 27771642 [TBL] [Abstract][Full Text] [Related]
59. Evaluation of Proactive and Reactive Strategies for Polio Eradication Activities in Pakistan and Afghanistan. Duintjer Tebbens RJ; Thompson KM Risk Anal; 2019 Feb; 39(2):389-401. PubMed ID: 30239026 [TBL] [Abstract][Full Text] [Related]